BIOHAVEN PHARMACEUTICAL HOLDING CO LTD stock forecast: up to 23.94 USD BHVN stock price prognosis


Forecast for Fri 19 May 2023 price 29.69

BIOHAVEN PHARMACEUTICAL HOLDING CO LTD stock price forecast for further price development up to 67.51% (time horizon: 1 day) and price target of 23.94 USD. Positive news sentiment. Short-term (time horizon: 2 weeks) BIOHAVEN PHARMACEUTICAL HOLDING CO LTD share price prediction for 2023-05-19 with daily closed price projections

Key Facts

Symbol BHVN 

ISIN USG111961052 

CUSIP G11196105

Currency USD

Category Pharmaceutical Preparations

Forecast price change %

News sentiment (0.81)

News <--> Close correlation for next day influence (-0.16)

Finance numbers

Revenue 106,299,000.0

Earnings per share -14.26

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

These benefits were sustained through 48 hours for some people. We are also working to bring NURTEC ODT to migraine suffers in international markets. In the United States, the prevalence rate is approximately 7%. Despite the approval of over two dozen agents, therapeutic effects are limited. The Company intends to advance BHV-1200 into a full clinical development program. Patents are a key determinant of market exclusivity for most pharmaceuticals. The patent applications have been filed in the U.S., Europe, Japan and other countries. Under the agreement, the Company may develop products based on the MoDE platform. Biohaven is obligated to pay FCCDC milestone payments for each NDA filing. A REMS can substantially increase the costs of obtaining approval. Section 505(b)(2) was enacted as part of the Hatch-Waxman Amendments. In August 2020, we drew down the first tranche of $275.0 million. There can be no assurance that any of these trials will produce positive results. In addition, there is a natural transition period when a new CRO commences work. If these collaborations are not successful, our business could be harmed. Any future collaborations that we enter into may not be successful. We have entered into several licenses to support our various programs. In March 2020, the World Health Organization declared COVID-19 a pandemic. The spread of COVID-19 may reduce access to NURTEC ODT.

Summerized Form 10-K with GPT-2
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 30.38/100
    • Not in ideal financial position.
    • Historical view, profit is growing.
    • Company revenue is not growing faster compared with the industry.
    • Stock price is under book price value.

Institutional ownership list is based on filling form information


CIK Name Date Action T-Test 1day T-Test 7day T-Test 14day T-Test 30day
1878290 Clark George C. 2022-05-10 SALE Accept Accept Accept Accept

Bollinger Bollinger Bands for BIOHAVEN PHARMACEUTICAL HOLDING CO LTD can provide the information where the market is moving based on price information.

BIOHAVEN PHARMACEUTICAL HOLDING CO LTD Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.


On-Balance Volume information for BIOHAVEN PHARMACEUTICAL HOLDING CO LTD. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for BIOHAVEN PHARMACEUTICAL HOLDING CO LTD. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for BIOHAVEN PHARMACEUTICAL HOLDING CO LTD. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for BIOHAVEN PHARMACEUTICAL HOLDING CO LTD. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for BIOHAVEN PHARMACEUTICAL HOLDING CO LTD. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for BIOHAVEN PHARMACEUTICAL HOLDING CO LTD. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for BIOHAVEN PHARMACEUTICAL HOLDING CO LTD. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

52W High 52W Low Market Cap

Similar shares



Figure below show the stock predictions.
Date Closing price Prediction was updated
2023-04-27 23.94 2023-03-25 04:05
2023-04-28 24.31 2023-03-25 04:05
2023-05-01 24.69 2023-03-25 04:05
2023-05-02 25.06 2023-03-25 04:05
2023-05-08 26.53 2023-03-25 04:05
2023-05-09 26.89 2023-03-25 04:05
2023-05-10 27.25 2023-03-25 04:05
2023-05-03 25.43 2023-03-25 04:05
2023-05-04 25.80 2023-03-25 04:05
2023-05-05 26.17 2023-03-25 04:05
2023-05-11 27.61 2023-03-25 04:05
2023-05-12 27.96 2023-03-25 04:05
2023-05-15 28.31 2023-03-25 04:05
2023-05-16 28.66 2023-03-25 04:05
2023-05-17 29.01 2023-03-25 04:05
2023-05-18 29.35 2023-03-25 04:05
2023-05-19 29.69 2023-03-25 04:05
2023-03-28 14.81 2023-03-25 04:05
2023-03-29 15.06 2023-03-25 04:05
2023-03-30 15.13 2023-03-25 04:05
2023-03-31 15.78 2023-03-25 04:05
2023-04-03 16.40 2023-03-25 04:05
2023-04-04 16.80 2023-03-25 04:05
2023-04-05 17.22 2023-03-25 04:05
2023-04-06 17.69 2023-03-25 04:05
2023-04-07 18.13 2023-03-25 04:05
2023-04-13 19.92 2023-03-25 04:05
2023-04-10 18.58 2023-03-25 04:05
2023-04-11 19.06 2023-03-25 04:05
2023-04-12 19.45 2023-03-25 04:05
2023-04-14 20.36 2023-03-25 04:05
2023-04-17 20.76 2023-03-25 04:05
2023-04-20 21.97 2023-03-25 04:05
2023-04-21 22.39 2023-03-25 04:05
2023-04-18 21.16 2023-03-25 04:05
2023-04-19 21.58 2023-03-25 04:05
2023-04-24 22.79 2023-03-25 04:05
2023-04-25 23.15 2023-03-25 04:05
2023-04-26 23.55 2023-03-25 04:05

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.